Summary
The idea of making oral contraceptives available without prescription has a long history, and has been recently revived in the US and the UK. High dose oral contraceptives have generally been replaced by low dose formulations and, subsequently, most cardiovascular risks have been reduced and a protection against ovarian and uterine cancers has been consistently demonstrated. Oral contraceptive compliance, however, continues to be a problem, but there is no reason to assume that wise practice would be any more or less if oral contraceptives were available over-the-counter (OTC). Some countries have introduced alternatives to prescription-only oral contraceptives, whereby nurses, midwives, social workers and/or pharmacists are incorporated into the distribution process. This article concludes that the balance of risks and benefits is in favour of OTC access for oral contraceptives.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
OCs o-t-c?[editorial]. Lancet 1993 Sept; 342(8871): 565–6
Petitti D. Safety of birth control pills. In: Samuels SE, Smith MD, editors. The pill: from prescription to over the counter. Menlo Park: Kaiser Family Foundation, 1994: 77–115
Vessey MP, Lawless M, Yeates D. Oral contraceptives and stroke: findings in a large prospective study. BMJ (Clin Res Ed) 1984; 289(64444): 530–1
Thorogood M, Mann J, Murphy M, et al. Is oral contraceptive use still associated with an increased risk of fatal myocardial infarction? Report of case control study. Br J Obstet Gynaecol 1991; 98(12): 1245–53
Gross T, Schelesselman JJ, Stadel BV, et al. The risk of epithelial ovarian cancer in short-term users of oral contraceptives. Am J Epidemiol 1992; 136(1): 46–53
Thomas DB. Oral contraceptives and breast cancer: review of epidemiological literature. Contraception 1991; 43(6): 597–642
Fortney JA, Harper JM, Potts M. Oral contraceptives and life expectancy. Stud Fam Plann 1986; 17(3): 117–25
Taylor H, Leitman R, Santana L. Survey of and barriers to pill use. In: Samuels SE, Smith MD, editors. The pill: from prescription to over the counter. Menlo Park: Kaiser Family Foundation, 1994: 53–76
Hatcher RA, Trussel J, Stewart F, et al. Contraceptive technology. New York: Irvington Publishers, 1994
Grady WR, Hayward MD, Yagi J. Contraceptive failure in the United States: estimates from the 1982 national survey of family growth. Fam Plann Perspec 1986; 18(5): 200–9
Potter LS. Oral contraceptive compliance and its role in the effectiveness of the method. In: Cramer JA, Spilker B, editors. Patient compliance in medical practice and clinical trials. New York: Raven Press, 1991: 195–207
Williams-Deane M, Potter LS. Current oral contraceptive use instructions: an analysis of patient package inserts. Fam Plann Perspec 1992; 24(3): 111–5
Ramsey S. What is the problem with emergency contraception? Lancet 1995; 345: 1169
Scheman CR. FDA policy opinion. In: Samuels SE, Smith MD, editors. The pill: from prescription to over the counter. Menlo Park: Kaiser Family Foundation, 1994: 243–50
Coeytaux FM, Allina A. The pill without prescription: the international experience. In: Samuels SE, Smith MD, editors. The pill: from prescription to over the counter. Menlo Park: Kaiser Family Foundation, 1994: 41–51
Americans exaggerate health risks of the pill and underestimate effectiveness of all contraceptives. Fam Plann Perspect 1985; 17: 128–9
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Potts, M., Denny, C. Safety Implications of Transferring the Oral Contraceptive from Prescription-Only to Over-the-Counter Status. Drug-Safety 13, 333–337 (1995). https://doi.org/10.2165/00002018-199513060-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-199513060-00002